Jacobs Solutions Inc. has had a significant year with a
mix of highs and lows.
Compass Wealth Management LLC and
Aaron Wealth Advisors LLC are among the many companies that hold a prominent position in the firm, with 87% of Jacobs Solutions' shares held by
institutional owners. However, the financial year has been turbulent for the biotech company, as key insiders have also sold shares, indicating hesitancy. The company has been successful in securing a major role in Dublin's BusConnects, leading to a boost in its stock performance. It has also shown strong financials despite recent stock weakness.
Fiduciary Alliance LLC invested $1.16 Million in Jacobs, and
JPMorgan Chase & Co. acquired more shares of the biotech company. Unfortunately, the company's stock underperformed compared to the market and the
S&P 500. On the brighter side, Jacobs Solutions has shown consistent growth in its short interest. The company's shares went down by 15.59% on Sep 30 but bounced back with a 3.3% rise on Nov 25. Jacobs Solutions also announced a spin-off, and its stock once again outperformed its competitors on strong trading days. Predictions for
Q4 2024 earnings report is positive while the company's stock hits a 52-week high at $148.9.
Jacobs Solutions Stocks News Analytics from Sat, 08 Mar 2014 08:00:00 GMT to Sat, 25 Jan 2025 14:48:48 GMT -
Rating 7
- Innovation 2
- Information 8
- Rumor -6
